Hikma appoints Riad Mishlawi as CEO
Hikma Pharmaceuticals
1,960.00p
16:45 03/05/24
1.82%
35.00p
Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.
FTSE 250
20,164.54
17:00 03/05/24
n/a
n/a
FTSE 350
4,515.50
16:54 03/05/24
n/a
n/a
FTSE All-Share
4,469.09
17:14 03/05/24
n/a
n/a
Pharmaceuticals & Biotechnology
23,112.61
16:54 03/05/24
-0.42%
-97.18
Said Darwazah will step down as acting CEO and return to his role as executive chairman.